Obesity treatment and the rise of the GLP-1 agonist 11 Sept Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous NHS Innovation Accelerator opens for applications Next Next Co-founder and CEO of @StartCodon Jason Mellad on helping healthcare start-ups thrive and why inclusion and diversity will change the world.
Obesity treatment and the rise of the GLP-1 agonist 11 Sept Written by Alexandra Collingbourne Alexandra Collingbourne
